<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T01:37:38Z</responseDate>
  <request identifier="oai:figshare.com:article/33946156" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33946156</identifier>
        <datestamp>2026-09-30T00:15:04Z</datestamp>
        <setSpec>category_24739</setSpec>
        <setSpec>portal_12</setSpec>
        <setSpec>item_type_5</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Sonalani Shandil: Microglial phenotypes in Amyotrophic Lateral Sclerosis linked to C9orf72, SOD1, or UBQLN2 genetic variants</dc:title>
          <dc:creator>Sonalani Shandil (8529651)</dc:creator>
          <dc:subject>Neurology and neuromuscular diseases</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>MND</dc:subject>
          <dc:subject>ALS</dc:subject>
          <dc:subject>Microglia</dc:subject>
          <dc:subject>Neuron</dc:subject>
          <dc:subject>StemCell</dc:subject>
          <dc:subject>Neuroinflammation</dc:subject>
          <dc:subject>Neurodegeneration</dc:subject>
          <dc:description>&lt;p dir="ltr"&gt;Background: ALS incidence in Aotearoa is among the highest globally. While ALS involves neuronal degeneration, microglia are recognised disease propagators, though whether different ALS-causing variants converge on a shared neuroinflammatory pathway or drive distinct microglial phenotypes remains unknown.Objectives: To determine how three ALS-causing variants alter homeostasis and inflammatory responses in iPSC-derived microglia.Methods: iPSC-microglia carrying C9orf72 HRE, SOD1A4V, or UBQLN2P506T variants (n=1 line/genotype), or isogenic controls, were stimulated with LPS/IFNγ (100 ng/mL) for 8 or 24 h. Immunofluorescence imaging quantified immunophenotype markers.Results: SOD1A4V microglia matched control immunophenotype, showing expected activation/chemokine marker upregulation. C9orf72 HRE microglia appeared constitutively primed, with elevated baseline C1q, IL-6, and delayed chemokine upregulation. UBQLN2P506T microglia initially responded but showed progressive loss of inflammatory signaling, with IL-6 and HLA-DR declining by 8 h and markedly reduced by 24 h.Discussion: ALS-associated microglial dysfunction appears genotype-dependent, with SOD1A4V retaining near-normal reactivity while C9orf72 HRE microglia show distinct, mutation-specific aberrant phenotypes.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-30T00:15:04Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Poster</dc:type>
          <dc:identifier>10.17608/k6.auckland.33946156.v2</dc:identifier>
          <dc:relation>https://figshare.com/articles/poster/Microglial_phenotypes_in_Amyotrophic_Lateral_Sclerosis_linked_to_C9orf72_SOD1_or_UBQLN2_genetic_variants/33946156</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
